News
Beyond DAXI, Revance gained exclusive rights to commercialize TEOXANE SA’s Resilient Hyaluronic Acid® (RHA®) line of fillers in the U.S., the first and only range of FDA-approved dermal ...
Resubmission of BLA for DAXI for glabellar lines achieved, PDUFA date established for September 8, 2022. The global Botulinum Toxin market is expected to reach $7.71 billion by 2027.
The Daxi Wood Art Ecomuseum, Taoyuan is hosting the First Daxi International Wood Furniture Craft and Design Competition with a prize pool of US$49,000(NT$1.5 million). The competition aims to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback